Pfizer Sued Over Termination Of Wyeth Patent Pact

Law360, New York (January 20, 2011, 2:46 PM EST) -- Pharmaceutical company Pfizer Inc. has been accused of unlawfully terminating a patent licensing agreement for imaging technology between AntiCancer Inc. and Wyeth following the merger of the two drug giants.

San Diego-based AntiCancer filed its complaint for breach of license agreement, breach of implied covenant of good faith and fair dealing and unjust enrichment against Pfizer and 10 unknown parties Wednesday in the U.S. District Court for the Southern District of California.

AntiCancer agreed to grant Wyeth a limited, nonexclusive license to its patented technologies as...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Anticancer, Inc. v. Pfizer, Inc. et al


Case Number

3:11-cv-00107

Court

California Southern

Nature of Suit

Contract: Other

Judge

Janis L. Sammartino

Date Filed

January 19, 2011

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.